Biocon launches generic Liraglutide in the UK for diabetes, obesity treatment

This launch follows the nod from the U.K.’s Medicines and Healthcare Products Regulatory Agency (MHRA), making Biocon the first generics company to receive approval for Liraglutide in a major regulated market.